| Literature DB >> 27384942 |
Thomas E Yankeelov1, Gary An2, Oliver Saut3, E Georg Luebeck4, Aleksander S Popel5, Benjamin Ribba6, Paolo Vicini7, Xiaobo Zhou8, Jared A Weis9, Kaiming Ye10, Guy M Genin11.
Abstract
Hierarchical processes spanning several orders of magnitude of both space and time underlie nearly all cancers. Multi-scale statistical, mathematical, and computational modeling methods are central to designing, implementing and assessing treatment strategies that account for these hierarchies. The basic science underlying these modeling efforts is maturing into a new discipline that is close to influencing and facilitating clinical successes. The purpose of this review is to capture the state-of-the-art as well as the key barriers to success for multi-scale modeling in clinical oncology. We begin with a summary of the long-envisioned promise of multi-scale modeling in clinical oncology, including the synthesis of disparate data types into models that reveal underlying mechanisms and allow for experimental testing of hypotheses. We then evaluate the mathematical techniques employed most widely and present several examples illustrating their application as well as the current gap between pre-clinical and clinical applications. We conclude with a discussion of what we view to be the key challenges and opportunities for multi-scale modeling in clinical oncology.Entities:
Keywords: Agent-based modeling; Cancer; Cancer screening; Computational modeling; Epidemiology; Mathematical modeling; Numerical modeling; Predictive oncology
Mesh:
Year: 2016 PMID: 27384942 PMCID: PMC4983505 DOI: 10.1007/s10439-016-1691-6
Source DB: PubMed Journal: Ann Biomed Eng ISSN: 0090-6964 Impact factor: 3.934